|
Tabla 3: Resultados primarios y secundarios. |
||||
|
Resultado |
Seguridad N = 402, n (%) |
Enoxaparina N = 214, n (%) |
Aspirina N = 188, n (%) |
p |
|
Sangrado mayor |
|
0 |
0 |
|
|
Sangrado menor |
7 (1.74) |
4 (1.86) |
3 (1.59) |
0.823604 |
|
Hematoma |
4 (1 ) |
2 (0.93) |
2 (1.06) |
|
|
Gatrointesinal |
0 |
0 |
0 |
|
|
Sangrado profuso del sitio quirúrgico |
1 (0.25) |
0 |
1(0.53) |
|
|
Equimosis |
2 (0.50) |
2 (0.93) |
0 |
|
|
Hemoptisis |
0 |
0 |
0 |
|
|
Hematuria |
0 |
0 |
0 |
|
|
Hemorragia conjuntival |
0 |
0 |
0 |
|
|
Resultados secundarios |
|
|
|
|
|
Infección de la herida |
5 (1.24) |
|
|
0.231768 |
|
Superficial |
|
2 (0.93) |
1 (0.53) |
|
|
Profunda |
|
0 |
0 |
|
|
Superficial > 30 días |
|
1 (0.46) |
1 (0.53) |
|
|
Profunda > 30 días |
|
0 |
0 |
|
|
IAM |
|
1 (0.46) |
0 |
|
|
EVC |
|
0 |
0 |
|
|
Muerte |
|
0 |
0 |
|
|
IAM = infarto agudo del miocardio, EVC = enfermedad vascular cerebral. |
||||